Eicosapentaenoic acid reduces pain by inhibiting vesicular nucleotide transporter-mediated ATP release (IMAGE)

Okayama University

Eicosapentaenoic acid reduces pain by inhibiting vesicular nucleotide transporter-mediated ATP release

Caption

New study identifies vesicular nucleotide transporter as a novel target of eicosapentaenoic acid (EPA) and highlights the mechanism underlying the analgesic effect of EPA. EPA potently attenuates neuropathic and inflammatory pain and insulin resistance, with fewer side effects

Credit

Takaaki Miyaji from Okayama University

Usage Restrictions

Do not reuse without permission

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.